•   
    ARVO 2016
    09:26
    Ocular Pathology/Oncology

    In this video from ARVO 2016, Dr. David Abramson discusses the development of intra-arterial chemotherapy for the treatment of retinoblastoma. While initially received with skepticism, the treatment is now considered standard of care for retinoblastoma, performed in more than 30 countries worldwide and resulting in no metastatic deaths and an enucleation rate of just 5%. Dr. Abramson also discusses the latest data on the intra-arterial agents used in the procedure and treatment indications.